학술논문
1300P Exploration of a novel HRD signature (HRDsig) as a biomarker of first line FOLFIRINOX benefit in metastatic pancreatic cancer
Document Type
Abstract
Author
Source
In Annals of Oncology September 2022 33 Supplement 7:S1138-S1138
Subject
Language
ISSN
0923-7534